Search Results - "Shibusawa, Ryo"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Effect of dapagliflozin on colon cancer cell [Rapid Communication] by Saito, Tsugumichi, Okada, Shuichi, Yamada, Eijiro, Shimoda, Yoko, Osaki, Aya, Tagaya, Yuko, Shibusawa, Ryo, Okada, Junichi, Yamada, Masanobu

    Published in ENDOCRINE JOURNAL (2015)
    “…Dapagliflozin is a SGLT2 (Sodium/Glucose cotransporter 2) inhibitor that reduces circulating glucose levels in type 2 diabetic patients by blocking the…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Fyn phosphorylates AMPK to inhibit AMPK activity and AMP-dependent activation of autophagy by Yamada, Eijiro, Okada, Shuichi, Bastie, Claire C, Vatish, Manu, Nakajima, Yasuyo, Shibusawa, Ryo, Ozawa, Atsushi, Pessin, Jeffrey E, Yamada, Masanobu

    Published in Oncotarget (15-11-2016)
    “…We previously demonstrated that proto-oncogene Fyn decreased energy expenditure and increased metabolic phenotypes. Also Fyn decreased autophagy-mediated…”
    Get full text
    Journal Article
  5. 5

    Effect of carbohydrate counting using bolus calculators on glycemic control in type 1 diabetes patients during continuous subcutaneous insulin infusion by Yamada, Eijiro, Okada, Shuichi, Nakajima, Yasuyo, Bastie, Claire C, Tagaya, Yuko, Osaki, Aya, Shimoda, Yoko, Shibusawa, Ryo, Saito, Tsugumichi, Ozawa, Atsushi, Yamada, Masanobu

    Published in Journal of diabetes investigation (01-07-2017)
    “…The present study examined the long‐term efficacy of insulin pump therapy for type 1 diabetes patients when carried out using carbohydrate counting with bolus…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Dapagliflozin rescues endoplasmic reticulum stress-mediated cell death by Shibusawa, Ryo, Yamada, Eijiro, Okada, Shuichi, Nakajima, Yasuyo, Bastie, Claire C., Maeshima, Akito, Kaira, Kyoichi, Yamada, Masanobu

    Published in Scientific reports (08-07-2019)
    “…The new type 2 diabetes drug, dapagliflozin, reduces blood glucose levels and body weight by inhibiting sodium glucose transporter 2 (SGLT2) in proximal…”
    Get full text
    Journal Article
  8. 8

    The Impact of Short-Term Professional Continuous Glucose Monitoring on Glycemic Control Via Lifestyle Improvement by Shibusawa, Ryo, Yamada, Eijiro, Okada, Shuichi, Nakajima, Yasuyo, Bastie, Claire C, Yamada, Masanobu

    Published in Diabetes technology & therapeutics (01-09-2018)
    “…The efficacy of short-term professional continuous glucose monitoring (CGM) for glycemic control in patients with diabetes remains unclear. We performed a…”
    Get more information
    Journal Article
  9. 9

    APPL1 promotes glucose uptake in response to mechanical stretch via the PKCζ-non-muscle myosin IIa pathway in C2C12 myotubes by Saito, Tsugumichi, Okada, Shuichi, Shimoda, Yoko, Tagaya, Yuko, Osaki, Aya, Yamada, Eijiro, Shibusawa, Ryo, Nakajima, Yasuyo, Ozawa, Atsushi, Satoh, Tetsurou, Mori, Masatomo, Yamada, Masanobu

    Published in Cellular signalling (01-11-2016)
    “…Expression of adaptor protein, phosphotyrosine interaction, pleckstrin homology domain, and leucine zipper containing 1 (APPL1) promoted glucose transporter 4…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    HBA1C AND MEAN GLUCOSE DERIVED FROM SHORT-TERM CONTINUOUS GLUCOSE MONITORING ASSESSMENT DO NOT CORRELATE IN PATIENTS WITH HBA1C >8 by Yamada, Eijiro, Okada, Shuichi, Nakajima, Yasuyo, Bastie, Claire C, Vatish, Manu, Tagaya, Yuko, Osaki, Aya, Shimoda, Yoko, Shibusawa, Ryo, Saito, Tsugumichi, Okamura, Takashi, Ozawa, Atsushi, Yamada, Masanobu

    Published in Endocrine practice (01-01-2017)
    “…Optimum therapy for patients with diabetes depends on both acute and long-term changes in plasma glucose, generally assessed by glycated hemoglobin (HbA1c)…”
    Get more information
    Journal Article
  15. 15

    Assessment of factors determining an HbA1c concentration ≤7.5% in patients with type 1 diabetes by Yamada, Eijiro, Okada, Shuichi, Nakajima, Yasuyo, Bastie, Claire, Tagaya, Yuko, Osaki, Aya, Shimoda, Yoko, Shibusawa, Ryo, Saito, Tsugumichi, Ozawa, Atsushi, Yamada, Masanobu

    Published in Journal of diabetes (01-02-2018)
    “…Background Establishing an optimal insulin regimen is crucial for maintaining glycemic control in patients with type 1 diabetes (T1D). The aim of the present…”
    Get full text
    Journal Article
  16. 16

    Assessment of factors determining an HbA1c concentration ≤7.5% in patients with type 1 diabetes: 评估决定1型糖尿病患者HbA1c≤7.5%的因素 by Yamada, Eijiro, Okada, Shuichi, Nakajima, Yasuyo, Bastie, Claire, Tagaya, Yuko, Osaki, Aya, Shimoda, Yoko, Shibusawa, Ryo, Saito, Tsugumichi, Ozawa, Atsushi, Yamada, Masanobu

    Published in Journal of diabetes (01-02-2018)
    “…Abstract Background Establishing an optimal insulin regimen is crucial for maintaining glycemic control in patients with type 1 diabetes ( T1D ). The aim of…”
    Get full text
    Journal Article
  17. 17

    Glycosuria medicated with ipragliflozin and nifedipine or ipragliflozin and candesartan: a case report by Okada, Shuichi, Shibusawa, Ryo, Tagaya, Yuko, Saito, Tsugumichi, Yamada, Eijiro, Shimoda, Yoko, Satoh, Tetsurou, Okada, Junichi, Yamada, Masanobu

    Published in Journal of medical case reports (16-12-2014)
    “…Animal studies have reported that treatment with angiotensin II receptor blockers reduced kidney sodium-dependent glucose cotransporter expression. We…”
    Get full text
    Journal Article